相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells
Roberta Cascella et al.
NATURE COMMUNICATIONS (2021)
Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer's disease
Dimitrios Sideris et al.
BRAIN COMMUNICATIONS (2021)
The Influence of Pathogenic Mutations in α-Synuclein on Biophysical and Structural Characteristics of Amyloid Fibrils
Francesco Simone Ruggeri et al.
ACS NANO (2020)
Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease
Aline Delva et al.
MOVEMENT DISORDERS (2020)
Single-molecule visualization of DNA G-quadruplex formation in live cells
Marco Di Antonio et al.
NATURE CHEMISTRY (2020)
Neuroinflammation and protein pathology in Parkinson's disease dementia
Antonina Kouli et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Mirror effect in atomic force microscopy profiles enables tip reconstruction
Francisco Marques-Moros et al.
SCIENTIFIC REPORTS (2020)
ThX - a next-generation probe for the early detection of amyloid aggregates
Lisa-Maria Needham et al.
CHEMICAL SCIENCE (2020)
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis
Craig D. Hughes et al.
ACTA NEUROPATHOLOGICA (2019)
Atomic force microscopy for single molecule characterisation of protein aggregation
Francesco Simone Ruggeri et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
NanoJ: a high-performance open-source super-resolution microscopy toolbox
Romain F. Laine et al.
JOURNAL OF PHYSICS D-APPLIED PHYSICS (2019)
Two conformationally distinct α-synuclein oligomers share common epitopes and the ability to impair long-term potentiation
Femke van Diggelen et al.
PLOS ONE (2019)
Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice
Jessica M. Froula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Increased Immune Activation by Pathologic α-Synuclein in Parkinson's Disease
Veselin Grozdanov et al.
ANNALS OF NEUROLOGY (2019)
Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes
Sarah H. Shahmoradian et al.
NATURE NEUROSCIENCE (2019)
Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms
Suman De et al.
NATURE COMMUNICATIONS (2019)
Parkinson's Disease in Women and Men: What's the Difference?
Silvia Cerri et al.
JOURNAL OF PARKINSONS DISEASE (2019)
Diffusible, highly bioactive oligomers represent a critical minority of soluble A beta in Alzheimer's disease brain
Wei Hong et al.
ACTA NEUROPATHOLOGICA (2018)
Super-resolution Imaging of Amyloid Structures over Extended Times by Using Transient Binding of Single Thioflavin T Molecules
Kevin Spehar et al.
CHEMBIOCHEM (2018)
Identification and nanomechanical characterization of the fundamental single-strand protofilaments of amyloid alpha-synuclein fibrils
Francesco Simone Ruggeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified α-synuclein
Phelippe Carmo-Goncalves et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
Danielle E. Mor et al.
NATURE NEUROSCIENCE (2017)
Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers
Giuliana Fusco et al.
SCIENCE (2017)
Endogenous Alpha-Synuclein Protein Analysis from Human Brain Tissues Using Single-Molecule Pull-Down Assay
Goun Je et al.
ANALYTICAL CHEMISTRY (2017)
Alpha-synuclein oligomers: a new hope
Nora Bengoa-Vergniory et al.
ACTA NEUROPATHOLOGICA (2017)
Ultrasensitive Measurement of Ca2+ Influx into Lipid Vesicles Induced by Protein Aggregates
Patrick Flagmeier et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Brain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice
Michael Helwig et al.
BRAIN (2016)
Alpha-synuclein activates BV2 microglia dependent on its aggregation state
Alana Hoffmann et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Intracellular soluble α-synuclein oligomers reduce pyramidal cell excitability
Timothy J. Kaufmann et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Nanoscale studies link amyloid maturity with polyglutamine diseases onset
F. S. Ruggeri et al.
SCIENTIFIC REPORTS (2016)
Influence of the β-Sheet Content on the Mechanical Properties of Aggregates during Amyloid Fibrillization
Francesco Simone Ruggeri et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
W. Peelaerts et al.
NATURE (2015)
High Stability and Cooperative Unfolding of α-Synuclein Oligomers
Wojciech Paslawski et al.
BIOCHEMISTRY (2014)
ThunderSTORM: a comprehensive ImageJ plug-in for PALM and STORM data analysis and super-resolution imaging
Martin Ovesny et al.
BIOINFORMATICS (2014)
Correction: Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
Tiago Fleming Outeiro et al.
PLoS One (2014)
Proteostasis impairment in protein-misfolding and -aggregation diseases
Mark S. Hipp et al.
TRENDS IN CELL BIOLOGY (2014)
Surface Passivation for Single-molecule Protein Studies
Stanley D. Chandradoss et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Prion-like spreading of pathological α-synuclein in brain
Masami Masuda-Suzukake et al.
BRAIN (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking
Bong-Kyu Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Structural and functional characterization of two alpha-synuclein strains
Luc Bousset et al.
NATURE COMMUNICATIONS (2013)
Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia
Changyoun Kim et al.
NATURE COMMUNICATIONS (2013)
Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons
Grit Taschenberger et al.
ACTA NEUROPATHOLOGICA (2012)
α-Synuclein misfolding and Parkinson's disease
Leonid Breydo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Nunilo Cremades et al.
CELL (2012)
Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
Kelvin C. Luk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Extracellular Alpha-Synuclein Oligomers Modulate Synaptic Transmission and Impair LTP Via NMDA-Receptor Activation
Maria Jose Diogenes et al.
JOURNAL OF NEUROSCIENCE (2012)
Accumulation of Toxic α-Synuclein Oligomer within Endoplasmic Reticulum Occurs in α-Synucleinopathy In Vivo
Emanuela Colla et al.
JOURNAL OF NEUROSCIENCE (2012)
Large Aggregates Are the Major Soluble Ab Species in AD Brain Fractionated with Density Gradient Ultracentrifugation
Dag Sehlin et al.
PLOS ONE (2012)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells
Mordhwaj S. Parihar et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Neurobiology and treatment of Parkinson's disease
Anthony H. V. Schapira
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Design of an N-methylated peptide inhibitor of α-synuclein aggregation guided by solid-state NMR
Jillian Madine et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Different species of α-synuclein oligomers induce calcium influx and seeding
Karin M. Danzer et al.
JOURNAL OF NEUROSCIENCE (2007)
Granular tau oligomers as intermediates of tau filaments
Sumihiro Maeda et al.
BIOCHEMISTRY (2007)
Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease
Melissa K. McCoy et al.
JOURNAL OF NEUROSCIENCE (2006)
Stages in the development of Parkinson's disease-related pathology
H Braak et al.
CELL AND TISSUE RESEARCH (2004)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Dependence of α-synuclein aggregate morphology on solution conditions
W Hoyer et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Vesicle permeabilization by protofibrillar α-synuclein:: Implications for the pathogenesis and treatment of Parkinson's disease
MJ Volles et al.
BIOCHEMISTRY (2001)
分享论文
